Shatzl T, Kaiser L, Deigner HP (2021) Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update. Orphanet J Rare Dis 16(1):129
Lemmers RJLF, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG et al (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329:1650–1653
Article CAS PubMed PubMed Central Google Scholar
Statland JM, Tawil R (2014) Risk of functional impairment in facioscapulohumeral muscular dystrophy. Muscle Nerve 49:520–527
Tawil R (2018) Facioscapulohumeral muscular dystrophy. Handb Clin Neurol 148:541–548
Leung DG (2018) Magnetic resonance imaging in facioscapulohumeral muscular dystrophy. Muscle Nerve 57(6):872
Article PubMed PubMed Central Google Scholar
Voermans NC, Vriens-Munoz Bravo M, Padberg GW, Laforêt P, FSHD European Trial Network workshop study group, van Alfen N, Attarian S et al (2021) 1st FSHD European Trial Network workshop: working towards trial readiness across Europe. Neuromuscul Disord 31(9):907–918
Article CAS PubMed Google Scholar
Warman-Chardon J, Diaz-Manera J, Tasca G, Straub V (2020) “247th ENMC International Workshop: muscle magnetic resonance imaging—implementing muscle MRI as a diagnostic tool for rare genetic myopathy cohorts”. Hoofddorp, The Netherlands, September 2019. Neuromuscul Disord 30(11):938–947
Dahlqvist JR, Andersen G, Khawajazada T, Vissing C, Thomsen C, Vissing J (2019) Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy. J Neurol 266(5):1127–1135
Monforte M, Laschena F, Ottaviani P, Bagnato MR, Pichiecchio A, Tasca G et al (2019) Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging. J Cachexia Sarcopenia Muscle 10(6):1258–1265
Article PubMed PubMed Central Google Scholar
Tasca G, Pescatori M, Monforte M, Mirabella M, Iannaccone E, Frusciante R et al (2012) Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS ONE 7(6):e38779
Article CAS PubMed PubMed Central Google Scholar
Tawil R, Padberg GW, Shaw DW, van der Maarel SM, Tapscott SJ (2016) Clinical trial preparedness in facioscapulohumeral muscular dystrophy: clinical, tissue, and imaging outcome measures. Neuromuscul Disord 26(2):181–186
Wang LH, Friedman SD, Shaw D, Snider L, Wong CJ, Budech CB et al (2019) MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD. Hum Mol Genet 28(3):476–486
Wong CJ, Wang LH, Friedman SD, Shaw D, Campbell AE, Budech CB et al (2020) Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies. Hum Mol Genet 29(6):1030–1043
Article CAS PubMed PubMed Central Google Scholar
Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M, Yamaguchi M, Ogawa R, Matev MM, Miyagoe-Suzuki Y, Takeda S, Tsujikawa K, Tsuchida K, Yamamoto H, Fukada S (2011) Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci 124(Pt 21):3654–3664
Article CAS PubMed Google Scholar
Farup J, Madaro L, Puri PL, Mikkelsen UR (2015) Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease. Cell Death Dis 6:e1830–e1913
Article CAS PubMed PubMed Central Google Scholar
Molina T, Fabre P, Dumont NA (2021) Fibro-adipogenic progenitors in skeletal muscle homeostasis, regeneration and diseases. Open Biol 11(12):210110
Article CAS PubMed PubMed Central Google Scholar
Theret M, Rossi FMV, Contreras O (2021) Evolving roles of muscle-resident fibro-adipogenic progenitors in health, regeneration, neuromuscular disorders, and aging. Front Physiol 12:673404
Article PubMed PubMed Central Google Scholar
Arahata K, Ishihara T, Fukunaga H, Orimo S, Lee JH, Goto K et al (1995) Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve Suppl 2:S56-66
Article CAS PubMed Google Scholar
Frisullo G, Frusciante R, Nociti R, Tasca G, Renna R, Iorio R et al (2011) CD8+ T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol 31(2):155–166
Article CAS PubMed Google Scholar
Statland JM, Shah B, Henderson D, Van Der Maarel S, Tapscott SJ, Tawil R (2015) Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies. Muscle Nerve 52(4):521–526
Article CAS PubMed PubMed Central Google Scholar
Di Pietro L, Giacalone F, Ragozzino E, Saccone V, Tiberio F, De Bardi M et al (2022) Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy type 1 patients. Cell Death Dis 13(9):793
Article PubMed PubMed Central Google Scholar
Bosnakovski D, Shams AS, Yuan C, da Silva MT, Ener ET, Baumann CW, Lindsay AJ et al (2020) Transcriptional and cytopathological hallmarks of FSHD in chronic DUX4-expressing mice. J Clin Invest 130(5):2465–2477
Article CAS PubMed PubMed Central Google Scholar
Statland JM, Odrzywolski KJ, Shah B, Henderson D, Fricke AF, van der Maarel SM, Tapscott SJ, Tawil R (2015) Immunohistochemical characterization of facioscapulohumeral muscular dystrophy muscle biopsies. J Neuromuscul Dis 2(3):291–299
Article PubMed PubMed Central Google Scholar
Tasca G, Monforte M, Ottaviani P, Pelliccioni M, Frusciante R, Laschena F et al (2016) Magnetic Resonance Imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials. Ann Neurol 79(5):854–864
Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B et al (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45(6):751–757
Article CAS PubMed Google Scholar
Patel H, Syddall HE, Martin HJ, Cooper C, Stewart C, Sayer AA (2011) The feasibility and acceptability of muscle biopsy in epidemiological studies: findings from the Hertfordshire Sarcopenia Study (HSS). J Nutr Health Aging 15:10–15
Fischer D, Kley RA, Strach K, Meyer C, Sommer T, Eger K et al (2008) Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 71(10):758–765
Article CAS PubMed PubMed Central Google Scholar
Mahdy MAA (2019) Skeletal muscle fibrosis: an overview. Cell Tissue Res 375(3):575–588
Duance VC, Stephens HR, Dunn M, Bailey AJ, Dubowitz V (1980) A role for collagen in the pathogenesis of muscular dystrophy? Nature 284(5755):470–472
Article CAS PubMed Google Scholar
Bell CD, Conen PE (1968) Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci 7(3):529–544
Article CAS PubMed Google Scholar
Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C (2009) Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 68(7):762–773
Bosnakovski D, Chan SSK, Recht OO, Hartweck LM, Gustafson CJ, Athman LL et al (2017) Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model. Nat Commun 8(1):550
Article PubMed PubMed Central Google Scholar
Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214(2):199–210
Article CAS PubMed PubMed Central Google Scholar
Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18(7):1028–40
Article CAS PubMed PubMed Central Google Scholar
Madaro L, Bouché M (2014) From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytes. Biomed Res Int 2014:438675
Article PubMed PubMed Central Google Scholar
Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, Muñoz-Cánoves P (2011) Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1(1):21
Comments (0)